{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:23Z","timestamp":1788873203142,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"funded by the Faculty of Medicine, Burapha University."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06165-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:06:37Z","timestamp":1782299197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors of atrial fibrillation in type 2 diabetes mellitus: a hospital-based cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-8977","authenticated-orcid":false,"given":"Sukrisd","family":"Koowattanatianchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimonsri","family":"Rangsrisaeneepitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonyaporn","family":"Pheugphoolphol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-3262","authenticated-orcid":false,"given":"Kiraphol","family":"Kaladee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2615-4222","authenticated-orcid":false,"given":"Chatchai","family":"Kreepala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"1","key":"6165_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"M Abdul Basith Khan","year":"2020","unstructured":"Abdul Basith Khan M, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. J Epidemiol global health. 2020;10(1):107\u201311.","journal-title":"J Epidemiol global health"},{"issue":"4","key":"6165_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J diabetes. 2015;6(4):598.","journal-title":"World J diabetes"},{"issue":"18","key":"6165_CR3","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"17","key":"6165_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","volume":"306","author":"WB Kannel","year":"1982","unstructured":"Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018\u201322.","journal-title":"N Engl J Med"},{"issue":"7","key":"6165_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.amjcard.2004.06.023","volume":"94","author":"J Friberg","year":"2004","unstructured":"Friberg J, Scharling H, Gadsb\u00f8ll N, Truelsen T, Jensen GB. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004;94(7):889\u201394.","journal-title":"Am J Cardiol"},{"issue":"7","key":"6165_CR6","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","volume":"126","author":"DA Lane","year":"2012","unstructured":"Lane DA, Lip GY. Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012;126(7):860\u20135.","journal-title":"Circulation"},{"issue":"3","key":"6165_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","volume":"105","author":"M-R Movahed","year":"2005","unstructured":"Movahed M-R, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105(3):315\u20138.","journal-title":"Int J Cardiol"},{"issue":"11","key":"6165_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271(11):840\u20134.","journal-title":"JAMA"},{"issue":"5","key":"6165_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","volume":"32","author":"D Aune","year":"2018","unstructured":"Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complicat. 2018;32(5):501\u201311.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"6165_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","volume":"108","author":"RR Huxley","year":"2011","unstructured":"Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis of cohort and case\u2013control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011;108(1):56\u201362.","journal-title":"Am J Cardiol"},{"key":"6165_CR11","doi-asserted-by":"crossref","unstructured":"Kreepala C, Famulski KS, Halloran PF. Fundamental Concepts Regarding Graft Injury and Regeneration: Tissue Injury, Tissue Quality, and Recipient Factors. Textbook organ transplantation. 2014:99\u2013118.","DOI":"10.1002\/9781118873434.ch10"},{"issue":"1","key":"6165_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-00013-6","volume":"15","author":"C Kreepala","year":"2025","unstructured":"Kreepala C, Ayutaya VSN, Phatthanakun R, Thabsuwan K, Paewponsong J. The biosensor using the target urine volatile organic compounds for detecting diabetic kidney disease. Sci Rep. 2025;15(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"6165_CR13","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41598-024-54138-1","volume":"14","author":"V Suthat Na Ayutaya","year":"2024","unstructured":"Suthat Na Ayutaya V, Tantisatirapoon C, Aekgawong S, Anakkamatee W, Danjittrong T, Kreepala C. Urinary cancer detection by the target urine volatile organic compounds biosensor platform. Sci Rep. 2024;14(1):3551.","journal-title":"Sci Rep"},{"issue":"2","key":"6165_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.23876\/j.krcp.20.190","volume":"40","author":"C Kreepala","year":"2021","unstructured":"Kreepala C, Panpruang P, Yodprom R, Piyajarawong T, Wattanavaekin K, Danjittrong T, et al. Manifestation of rs1888747 polymorphisms in the FRMD3 gene in diabetic kidney disease and diabetic retinopathy in type 2 diabetes patients. Kidney Res Clin Pract. 2021;40(2):263.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"6165_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13561-025-00649-0","volume":"15","author":"N Khomsanoi","year":"2025","unstructured":"Khomsanoi N, Chombandit T, Wiwatmanaskul J, Kreepala C. Economic evaluation of inpatient medication reconciliation with a subtraction strategy. Health Econ Rev. 2025;15(1):1\u201310.","journal-title":"Health Econ Rev"},{"issue":"1","key":"6165_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-019-0983-1","volume":"19","author":"S Seyed Ahmadi","year":"2020","unstructured":"Seyed Ahmadi S, Svensson A-M, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"Supplement1","key":"6165_CR17","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/dc23-Srev","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Summary of revisions: standards of care in diabetes\u20142023. Diabetes Care. 2023;46(Supplement1):S5\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"6165_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"9403","key":"6165_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","journal-title":"Lancet"},{"issue":"9","key":"6165_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"6165_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10157-014-1057-z","volume":"19","author":"M Haneda","year":"2015","unstructured":"Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. Clin Exp Nephrol. 2015;19(1):1\u20135.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"6165_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s13340-021-00563-w","volume":"13","author":"N Honda","year":"2022","unstructured":"Honda N, Ochi A, Uchimoto S, Kakutani Y, Yamazaki Y, Morioka T, et al. Factors associated with atrial fibrillation in Japanese patients with type 2 diabetes mellitus: a cross-sectional study. Diabetol Int. 2022;13(3):503\u201312.","journal-title":"Diabetol Int"},{"key":"6165_CR23","doi-asserted-by":"crossref","unstructured":"GHERASIM L. Association of atrial fibrillation with diabetes mellitus, high risk comorbidities. Maedica. 2022;17(1):143.","DOI":"10.26574\/maedica.2022.17.1.143"},{"issue":"5","key":"6165_CR24","first-page":"e007030","volume":"12","author":"MV Fangel","year":"2019","unstructured":"Fangel MV, Nielsen PB, Kristensen JK, Larsen TB, Overvad TF, Lip GY, et al. Glycemic status and thromboembolic risk in patients with atrial fibrillation and type 2 diabetes mellitus: a Danish cohort study. Circulation: Arrhythmia Electrophysiol. 2019;12(5):e007030.","journal-title":"Circulation: Arrhythmia Electrophysiol"},{"issue":"1","key":"6165_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-021-01318-2","volume":"20","author":"J Gumprecht","year":"2021","unstructured":"Gumprecht J, Lip GY, Sokal A, \u015aredniawa B, Mitr\u0119ga K, Stokwiszewski J, et al. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study. Cardiovasc Diabetol. 2021;20(1):128.","journal-title":"Cardiovasc Diabetol"},{"issue":"Supplement1","key":"6165_CR26","first-page":"zwad125","volume":"30","author":"F Kalokola","year":"2023","unstructured":"Kalokola F, Salla A, Kalluvya S. Prevalence of atrial fibrillation and its associated factors among type 2 diabetics attending a tertiary hospital. Eur J Prev Cardiol. 2023;30(Supplement1):zwad125.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"6165_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13340-021-00509-2","volume":"13","author":"S Otake","year":"2022","unstructured":"Otake S, Sato A, Babazono T. Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes. Diabetol Int. 2022;13(1):101\u20137.","journal-title":"Diabetol Int"},{"issue":"2","key":"6165_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J stroke. 2021;16(2):217\u201321.","journal-title":"Int J stroke"},{"issue":"6","key":"6165_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/2047487315599892","volume":"23","author":"JL Pallisgaard","year":"2016","unstructured":"Pallisgaard JL, Schjerning A-M, Lindhardt TB, Procida K, Hansen ML, Torp-Pedersen C, et al. Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study. Eur J Prev Cardiol. 2016;23(6):621\u20137.","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"6165_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","volume":"74","author":"A Wang","year":"2019","unstructured":"Wang A, Green JB, Halperin JL, Piccini JP. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74(8):1107\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6165_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1540-8167.2007.00781.x","volume":"18","author":"W Wongcharoen","year":"2007","unstructured":"Wongcharoen W, CHEN YC, CHEN YJ, LIN CI, CHEN SA. Effects of aging and ouabain on left atrial arrhythmogenicity. J Cardiovasc Electrophys. 2007;18(5):526\u201331.","journal-title":"J Cardiovasc Electrophys"},{"issue":"1","key":"6165_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15420\/ecr.2014.9.1.37","volume":"9","author":"D Tousoulis","year":"2014","unstructured":"Tousoulis D, Oikonomou E, Siasos G, Stefanadis C. Diabetes mellitus and heart failure. Eur Cardiol Rev. 2014;9(1):37.","journal-title":"Eur Cardiol Rev"},{"issue":"23","key":"6165_CR33","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920\u20135.","journal-title":"Circulation"},{"issue":"17","key":"6165_CR34","doi-asserted-by":"publisher","first-page":"e022222","DOI":"10.1161\/JAHA.121.022222","volume":"10","author":"AK Pandey","year":"2021","unstructured":"Pandey AK, Okaj I, Kaur H, Belley-Cote EP, Wang J, Oraii A, et al. Sodium\u2010glucose co\u2010transporter inhibitors and atrial fibrillation: a systematic review and meta\u2010analysis of randomized controlled trials. J Am Heart Association. 2021;10(17):e022222.","journal-title":"J Am Heart Association"},{"issue":"1","key":"6165_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-020-01105-5","volume":"19","author":"W-j Li","year":"2020","unstructured":"Li W-j, Chen X-q, Xu L-l, Li Y-q. Luo B-h. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials. Cardiovasc Diabetol. 2020;19(1):130.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6165_CR36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s12872-024-04454-1","volume":"24","author":"S Aydemir","year":"2024","unstructured":"Aydemir S, Ayd\u0131n S\u015e, Aksakal E, Alt\u0131nkaya O, \u00d6zmen M, Birdal O. Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation. BMC Cardiovasc Disord. 2024;24(1):760.","journal-title":"BMC Cardiovasc Disord"},{"key":"6165_CR37","doi-asserted-by":"publisher","first-page":"108861","DOI":"10.1016\/j.pharmthera.2025.108861","volume":"270","author":"M Armillotta","year":"2025","unstructured":"Armillotta M, Angeli F, Paolisso P, Belmonte M, Raschi E, Di Dalmazi G, et al. Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacol Ther. 2025;270:108861.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6165_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12872-024-03784-4","volume":"24","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhang R, Zhang X, Xu W. Association between baseline glycated hemoglobin level and atrial fibrillation recurrence following cryoballoon ablation among patients with and without diabetes. BMC Cardiovasc Disord. 2024;24(1):111.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"6165_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.amjmed.2005.01.031","volume":"118","author":"L Frost","year":"2005","unstructured":"Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005;118(5):489\u201395.","journal-title":"Am J Med"},{"issue":"21","key":"6165_CR40","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","volume":"55","author":"UB Tedrow","year":"2010","unstructured":"Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, et al. The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women\u2019s Health Study). J Am Coll Cardiol. 2010;55(21):2319\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6165_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42444-021-00048-6","volume":"22","author":"S Rafaqat","year":"2021","unstructured":"Rafaqat S, Rafaqat S, Rafaqat S. Pathophysiological role of major adipokines in Atrial Fibrillation. Int J Arrhythmia. 2021;22(1):18.","journal-title":"Int J Arrhythmia"},{"key":"6165_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fphys.2019.00135","volume":"10","author":"LJ Bohne","year":"2019","unstructured":"Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM. The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights. Front Physiol. 2019;10:135.","journal-title":"Front Physiol"},{"issue":"14","key":"6165_CR43","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"key":"6165_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ijcard.2018.02.051","volume":"261","author":"Y Li","year":"2018","unstructured":"Li Y, Pastori D, Guo Y, Wang Y, Lip GY. Risk factors for new-onset atrial fibrillation: a focus on Asian populations. Int J Cardiol. 2018;261:92\u20138.","journal-title":"Int J Cardiol"},{"issue":"1","key":"6165_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12916-024-03792-3","volume":"22","author":"DA Mei","year":"2024","unstructured":"Mei DA, Romiti GF, Bucci T, Corica B, Imberti JF, Bonini N, et al. Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries. BMC Med. 2024;22(1):567.","journal-title":"BMC Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06165-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:04:09Z","timestamp":1788872649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6165"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06165-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"780"}}